Proteasome inhibitors as reversers of resistance to artemisinin-based antimalarials

Tilley, Leann (Primary Chief Investigator (PCI))
Charman, Susan (Chief Investigator (CI))

Centre for Drug Candidate Optimisation

Project: Research

Status	Finished
Effective start/end date	1/01/15 → 31/12/16

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$100,000.00

1 Article

Comparison of the exposure time dependence of the activities of synthetic ozonide antimalarials and dihydroartemisinin against K13 wild-type and mutant Plasmodium falciparum strains
Yang, T., Xie, S. C., Cao, P., Giannangelo, C., McCaw, J., Creek, D. J., Charman, S. A., Klonis, N. & Tilley, L., 1 Aug 2016, In: Antimicrobial Agents and Chemotherapy. 60, 8, p. 4501-4510 10 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

48 Citations (Scopus)